Here, we show that transfection with the VEGF-A inhibitor gene sFlt-1 in mice with diabetic nephropathy reverses pre-existing kidney damage by normalising albumin:creatinine levels and mesangial matrix content. This evidence concerns the gene ALB and Nephropathy.